by Ming Mui | Oct 29, 2024 | Biotechnology, Investing News, Market News, Medical Use, Pharmaceutical, Stock Market
TransMedics Group, Inc. (TMDX) experienced a dramatic 30% drop in its stock price during early morning trading, despite reporting impressive revenue growth. The company announced total revenue of $108.8 million for Q3 2024, representing a remarkable 64% increase...
